Silencing KRT19 resulted in decreased cell proliferation, migration, and survival, by decreasing the expression of PTEN through reduced expression of Egr1 and importin-7 and also regulated the nuclear import of β-catenin/RAC1 complex, thus modulating the NOTCH pathway in breast cancer [308]. This evidence concerns the gene RAC1 and breast carcinoma.